Ocular Therapeutix (OCUL) Leases (2019 - 2026)
Ocular Therapeutix's quarterly Leases came in at $6.5 million in Q1 2026, up 11.44% year-on-year from $5.8 million in Q1 2025, and up 40.04% quarter-over-quarter from $4.6 million in Q4 2025.
Ocular Therapeutix has reported Leases for 8 years, with the latest figure at $6.5 million in Q1 2026.
- For the quarter ending Q1 2026, Leases rose 11.44% year-over-year to $6.5 million; the trailing twelve-month figure through Mar 2026 stood at $6.5 million (up 11.44% YoY), and the FY2025 full-year result was $4.6 million, down 21.98% from the prior year.
- Leases for Q1 2026 stood at $6.5 million, up from $4.6 million in the prior quarter.
- The five-year high for Leases was $8.0 million in Q4 2022, with the low at $4.0 million in Q3 2022.
- Average Leases over 5 years is $5.9 million, with a median of $5.9 million recorded in 2024.
- Year-over-year, Leases jumped 71.53% in 2023 and decreased 21.98% in 2025.
- Tracing OCUL's Leases over 5 years: stood at $8.0 million in 2022, then slipped by 19.52% to $6.5 million in 2023, then retreated by 8.14% to $5.9 million in 2024, then declined by 21.98% to $4.6 million in 2025, then soared by 40.04% to $6.5 million in 2026.
- The last three Leases figures came in at $6.5 million (Q1 2026), $4.6 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | 6.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.50 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Sep 30, 2025 | 5.33 Mn |
| Jun 30, 2025 | 5.88 Mn |
| Mar 31, 2025 | 5.83 Mn |
| Dec 31, 2024 | 5.95 Mn |
| Sep 30, 2024 | 5.69 Mn |
| Jun 30, 2024 | 6.01 Mn |
| Mar 31, 2024 | 6.06 Mn |
| Dec 31, 2023 | 6.47 Mn |
| Sep 30, 2023 | 6.87 Mn |
| Jun 30, 2023 | 7.25 Mn |
| Mar 31, 2023 | 7.63 Mn |
| Dec 31, 2022 | 8.04 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 4.31 Mn |
| Mar 31, 2022 | 4.59 Mn |
| Dec 31, 2021 | 4.87 Mn |
| Sep 30, 2021 | 5.13 Mn |
| Jun 30, 2021 | 5.38 Mn |
| Mar 31, 2021 | 5.62 Mn |
| Dec 31, 2020 | 5.84 Mn |
| Sep 30, 2020 | 6.06 Mn |
| Jun 30, 2020 | 6.27 Mn |
| Mar 31, 2020 | 6.47 Mn |
| Dec 31, 2019 | 6.66 Mn |
| Sep 30, 2019 | 6.84 Mn |
| Jun 30, 2019 | 7.01 Mn |
| Mar 31, 2019 | 5.16 Mn |